Zepbound Clinical Trial Findings

Order byBest matchMost fresh

Zepbound beats Wegovy for weight loss

This drug led to 50% more weight loss than Wegovy in head-to-head study

After 72 weeks, participants receiving the Zepbound injections lost an average of 50 pounds, or 20% of their body weight.

· 1d

· 2d · on MSN

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

Becker's Hospital Review · 2d

Zepbound beats Wegovy for weight loss: Study

What is the most effective weight loss drug?

drug maker Eli Lilly put its own weight loss drug Zepbound against the popular drug Wegovy, and Zepbound outperformed, causing 6% more weight loss than its competitor.

· 1d

· 2d

New study compares Wegovy and Zepbound for the first time

· 2d

Study finds Zepbound may help people lose more weight than Wegovy

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.

New Atlas1d

Dual-target weight-loss drug is 47% more effective than its rival

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference. And one clearly comes out on top.